PATENT CLAIM ANALYSIS

Application Number: 16452691
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["514", "275000"]

Abstract:
Provided herein are isotopologues of Compound A, which are enriched with isotopes such as, for example, deuterium. Pharmaceutical compositions comprising the isotope-enriched compounds, and methods of using such compounds are also provided.

Claim (Index 7):
A method of treating a liver fibrotic disorder, diabetes or a metabolic syndrome leading to a liver fibrotic disorder comprising administering to a patient having a liver fibrotic disorder, diabetes or a metabolic syndrome leading to a liver fibrotic disorder a compound of  claim 1 , or a pharmaceutically acceptable salt or solvate thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 100.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13979602', '14726287', '14425479', '14026794', '15881501']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7366700673116374
- 35 USC 102 Novelty (BERT): 0.5031392354561142
- Combined Prediction Score: 0.713316984126085
- Mean Citation Score: 211.550698
- Max Citation Score: 223.44891
- Similarity Product: 141.23384864654662

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test